For a patient discharged after treatment for plasma cryoprecipitate, what is the principal ICD-10-CM diagnosis code?

• A. D68.00
• B. I21.09
• C. E11.621
• D. F11.922

Answer: (A)

The principal ICD-10-CM diagnosis code for a patient discharged after treatment for plasma cryoprecipitate is D68.00. This code specifically refers to a disorder of coagulation due to a deficiency of coagulation factor VIII, which can be associated with conditions requiring the use of plasma cryoprecipitate during treatment.

Plasma cryoprecipitate is typically administered to patients who are experiencing bleeding due to clotting factor deficiencies. Therefore, D68.00 appropriately reflects the underlying diagnosis that necessitated treatment with plasma cryoprecipitate. This code highlights the focus on bleeding disorders related to clotting factors, ensuring that medical records accurately capture the reason for transfusion and subsequent treatment.

In contrast, the other codes pertain to different medical conditions: I21.09 represents a non-ST elevation myocardial infarction, E11.621 indicates type 2 diabetes with foot ulcer, and F11.922 denotes opioid dependence. None of these options directly correlate with the treatment or condition related to plasma cryoprecipitate. Hence, D68.00 is the most relevant and accurate code in this context.